Key Takeaways
- American Express delivers Q1 results on April 23, with analysts projecting approximately 9.6% YoY increases in both earnings per share and revenue
- Cardholder spending (billed business) expanded 8% YoY in Q4 2025, but momentum has plateaued and shows no signs of reaccelerating
- Credit metrics remain healthy — charge-offs have risen modestly, while reserve additions are tapering
- Full-year 2026 outlook projects 9–10% revenue expansion and EPS between $17.30 and $17.90, matching Street expectations
- Analyst consensus rates the stock Moderate Buy, with a mean price target of $352.60 (representing ~6.3% potential gain)
American Express (AXP) approaches its Q1 2026 earnings announcement on April 23 with fundamentals that look respectable — but that might be precisely where the challenge lies.
The company’s underlying business remains healthy. Consumer spending patterns are stable. Credit performance is acceptable. Yet for a stock that continues to command a premium valuation, “acceptable” may not be sufficient to drive meaningful price appreciation.
Analysts are forecasting roughly 9.6% year-over-year expansion in both earnings and top-line results. That represents consistency. It just doesn’t inspire excitement.
The central concern centers on billed business — the measurement of cardholder spending — which represents the most critical metric investors track for AXP. This figure posted 8% YoY growth in Q4 2025, consistent with full-year FY25 performance. However, after climbing from 6% in Q1 2025 to 7% in Q2, the growth rate has essentially stagnated.
This pattern increasingly resembles a mature, stable business model — a characterization that doesn’t align comfortably with the stock’s 21.4x trailing earnings valuation.
Credit Metrics Show Stability, Not Stress
On the credit quality front, concerns remain minimal. Charge-offs reached $1.27 billion in Q4, compared to $1.13 billion in the prior-year period, though the quarter-over-quarter increase proved modest.
Provisions climbed to $1.41 billion from Q3’s $1.28 billion. However, the reserve build totaled just $141 million — significantly below the $222 million recorded in Q2 2025. This isn’t a red flag. It reflects volume-related adjustments rather than credit concerns.
Net interest income jumped 12% YoY, loan balances expanded 7%, and interest margins widened. These indicators point to credit expansion that remains both profitable and disciplined. The takeaway: normalization in progress, not quality erosion.
Cramer’s Take on Timing
Jim Cramer highlighted AXP during a recent Mad Money segment, offering a tactical warning for investors considering positions ahead of the report.
“American Express almost always seems to retreat when we see the numbers and then runs a couple of days later,” Cramer noted. His recommendation: hold off until the close of earnings day — or the next morning — to sidestep the “knee-jerk selling” that frequently follows even strong quarterly results.
Cramer has also emphasized AXP’s affluent customer base as a fundamental advantage. “Demand for premium products can stay strong even if the rest of the economy slows down,” he observed in early April.
Bank of America’s Q1 earnings, released April 15, provide a useful barometer for consumer spending health. Card spending grew 6% YoY, with particular strength in travel, services, and retail categories. Given Amex’s affluent customer demographic, the company likely performed at or above this level — suggesting high single-digit billed business growth represents the baseline expectation for Q1.
AXP currently trades around 18.5x forward earnings, approximately 20% below its December valuation peak. This multiple compression creates somewhat more favorable conditions for upside movement.
The FY26 outlook anticipates 9–10% revenue growth and EPS ranging from $17.30 to $17.90 — representing roughly 14% YoY earnings growth. Analysts have largely maintained their projections following this guidance release.
Among the most recent 17 analyst ratings, seven recommend Buy, nine suggest Hold, and one advises Sell. The consensus price target stands at $352.60, indicating approximately 6.3% upside potential from present trading levels.
